Moxifloxacin + BromfenacThird Party Manufacturing in India

Moxifloxacin + Bromfenac works by providing structural protection against bacterial growth and ocular pain. Moxifloxacin prevents bacterial recovery and replication by binding to and inhibiting essential topoisomerase IV and DNA gyrase enzymes. Bromfenac sodium serves as a highly potent non-steroidal anti-inflammatory drug that blocks the cyclooxygenase-2 enzyme, stopping the transformation of arachidonic acid into prostaglandins that induce ocular pain, miosis, and blood-aqueous barrier disruption. Unlike corticosteroid combinations, it controls swelling and discomfort without risking secondary glaucoma. It is highly effective and well-tolerated.

Therapeutic Uses

• Post-Cataract Pain Management: Minimizes acute aching and burning sensations following intraocular lens implantation surgeries.
• Cystoid Macular Edema Prophylaxis: Lowers the clinical incidence of macular swelling after routine ophthalmic surgeries.
• Infectious Ocular Pain: Restores comfort in cases of bacterial conjunctivitis that present with severe physical irritation.

Why Manufacturers Choose Moxifloxacin + Bromfenac

As standard clinical guidelines shift away from steroids to avoid pressure risks, this NSAID-antibiotic pair has experienced significant demand acceleration. Securing Moxifloxacin + Bromfenac third party manufacturing in India places your brand at the forefront of modern ophthalmic care. Our production facilities are WHO-GMP certified, featuring strict quality oversight to maintain the optimal pH and stability required for this active CAS 135738-90-2 and bromfenac liquid solution.